202 related articles for article (PubMed ID: 33870788)
1. Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis.
Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DD; Moore JJ; Massey JC
Mult Scler; 2021 Nov; 27(13):2112-2115. PubMed ID: 33870788
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
Zafeiri L; Åkerfeldt T; Tolf A; Carlson K; Skalkidou A; Burman J
PLoS One; 2023; 18(4):e0284288. PubMed ID: 37043510
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.
Mehra V; Rhone E; Widya S; Zuckerman M; Potter V; Raj K; Kulasekararaj A; McLornan D; de Lavallade H; Benson-Quarm N; Lim C; Ware S; Sudhanva M; Malik O; Nicholas R; Muraro PA; Marsh J; Mufti GJ; Silber E; Pagliuca A; Kazmi MA
Clin Infect Dis; 2019 Oct; 69(10):1757-1763. PubMed ID: 30980715
[TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective.
Bose G; Thebault S; Rush CA; Atkins HL; Freedman MS
Mult Scler; 2021 Feb; 27(2):167-173. PubMed ID: 32364422
[TBL] [Abstract][Full Text] [Related]
6. Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis.
Massarotti C; Sbragia E; Boffa G; Vercelli C; Zimatore GB; Cottone S; Frau J; Raiola A; Varaldo R; Mancardi G; Inglese M; Anserini P
Mult Scler; 2021 Nov; 27(13):2103-2107. PubMed ID: 33709839
[TBL] [Abstract][Full Text] [Related]
7. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF
J Neurol Neurosurg Psychiatry; 2019 May; 90(5):514-521. PubMed ID: 30538138
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.
Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ
Front Immunol; 2021; 12():782935. PubMed ID: 35126353
[TBL] [Abstract][Full Text] [Related]
9. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
Vaivade A; Wiberg A; Khoonsari PE; Carlsson H; Herman S; Al-Grety A; Freyhult E; Olsson-Strömberg U; Burman J; Kultima K
Lipids Health Dis; 2023 Jul; 22(1):97. PubMed ID: 37420217
[TBL] [Abstract][Full Text] [Related]
10. Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Lachnit M; Revendova KZ; Hradilek P; Bunganic R; Koristek Z; Jelinek T; Skutova M; Piza R; Volny O; Hajek R; Bar M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):50-54. PubMed ID: 37337857
[TBL] [Abstract][Full Text] [Related]
11. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
[TBL] [Abstract][Full Text] [Related]
12. Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis.
Kasarełło K; Snarski E; Sulejczak D; Ciesielski T; Wiśniewska A; Wrzesień R; Cudnoch-Jędrzejewska A
Arch Immunol Ther Exp (Warsz); 2021 Jun; 69(1):17. PubMed ID: 34181099
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis.
Mariottini A; Bulgarini G; Forci B; Innocenti C; Mealli F; Mattei A; Ceccarelli C; Repice AM; Barilaro A; Mechi C; Saccardi R; Massacesi L
Eur J Neurol; 2022 Jun; 29(6):1708-1718. PubMed ID: 35146841
[TBL] [Abstract][Full Text] [Related]
14. Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.
de Oliveira GL; Ferreira AF; Gasparotto EP; Kashima S; Covas DT; Guerreiro CT; Brum DG; Barreira AA; Voltarelli JC; Simões BP; Oliveira MC; de Castro FA; Malmegrim KC
Clin Exp Immunol; 2017 Mar; 187(3):383-398. PubMed ID: 28008595
[TBL] [Abstract][Full Text] [Related]
15. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Atkins HL; Bowman M; Allan D; Anstee G; Arnold DL; Bar-Or A; Bence-Bruckler I; Birch P; Bredeson C; Chen J; Fergusson D; Halpenny M; Hamelin L; Huebsch L; Hutton B; Laneuville P; Lapierre Y; Lee H; Martin L; McDiarmid S; O'Connor P; Ramsay T; Sabloff M; Walker L; Freedman MS
Lancet; 2016 Aug; 388(10044):576-85. PubMed ID: 27291994
[TBL] [Abstract][Full Text] [Related]
16. Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J
Cytotherapy; 2023 Dec; 25(12):1271-1276. PubMed ID: 37737765
[TBL] [Abstract][Full Text] [Related]
17. Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Muraro PA; Pasquini M; Atkins HL; Bowen JD; Farge D; Fassas A; Freedman MS; Georges GE; Gualandi F; Hamerschlak N; Havrdova E; Kimiskidis VK; Kozak T; Mancardi GL; Massacesi L; Moraes DA; Nash RA; Pavletic S; Ouyang J; Rovira M; Saiz A; Simoes B; Trnený M; Zhu L; Badoglio M; Zhong X; Sormani MP; Saccardi R;
JAMA Neurol; 2017 Apr; 74(4):459-469. PubMed ID: 28241268
[TBL] [Abstract][Full Text] [Related]
18. Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.
Das J; Snowden JA; Burman J; Freedman MS; Atkins H; Bowman M; Burt RK; Saccardi R; Innocenti C; Mistry S; Laud PJ; Jessop H; Sharrack B
Mult Scler; 2021 Jul; 27(8):1198-1204. PubMed ID: 33565902
[TBL] [Abstract][Full Text] [Related]
19. Cryopreservation of ovarian tissue as fertility preservation in young women with multiple sclerosis before stem cell transplantation.
Colmorn LB; Kristensen SG; Larsen EC; Macklon KT
Mult Scler Relat Disord; 2023 Jun; 74():104716. PubMed ID: 37087965
[TBL] [Abstract][Full Text] [Related]
20. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
